Effect of systemic B-type natriuretic peptide on cardiac vagal motoneuron activity

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 293, Issue 6, 2007, Pages

  Toader, E ^a   McAllen, R M ^b   Cividjian, A ^a   Woods, R L ^b   Quintin, L ^a,c  

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c Laboratoire de Physiologie Int&EACUTE grative Cellulaire et Mol&EACUTE culaire Villeurbanne   (France)

Author keywords

Bradycardia; Cardiopulmonary; Chemoreflex; Heart; Parasympathetic; Phenyl biguanide; Single unit activity; Vagus; Von Bezold Jarisch

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; PHENYLBIGUANIDE;

AMBIGUUS NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDROMIC STIMULATION; ARTICLE; BRADYCARDIA; CONTROLLED STUDY; HEART RIGHT ATRIUM; MALE; MOTONEURON; NONHUMAN; PRIORITY JOURNAL; RAT; VAGUS NERVE;

ACTION POTENTIALS; ANIMALS; BAROREFLEX; BIGUANIDES; BRADYCARDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; EFFERENT PATHWAYS; ELECTRIC STIMULATION; HEART; HEART RATE; INFUSIONS, INTRAVENOUS; MALE; MOTOR NEURONS; NERVE TISSUE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; VAGOTOMY; VAGUS NERVE;

EID: 36849017077     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00528.2007     Document Type: Article

References (32)

1. Ackermann U, Irizawa TG, Milojevic S, Sonnenberg H. Cardiovascular effects of atrial extracts in anesthetized rats. Can J Physiol Pharmacol 62: 819-826, 1984.
2. Atchison DJ, Ackermann U. Influence of atrial natriuretic factor on autonomic control of heart rate. Am J Physiol Regul Integr Comp Physiol 258: R718-R723, 1990.
3. Brunner-La Rocca HP, Kaye DM, Woods RL, Hastings J, Esler M. Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy subjects. J Am Coll Cardiol 37: 1221-1227, 2001.
4. + channel blockade in the NTS alters efficacy of two cardiorespiratory reflexes in vivo. Am J Physiol Regul Integr Comp Physiol 274: R677-R685, 1998.
5. Colucci WS. Nesiritide for the treatment of decompensated heart failure. J Card Fail 7: 92-100, 2001.
6. Deliva RD, Ackermann U. Atrial natriuretic peptide and mechanisms of cardiovascular control. Role of serotoninergic receptors. Am J Physiol Regul Integr Comp Physiol 274: R711-R717, 1998.
7. Floras JS. Inhibitory effect of atrial natriuretic factor on sympathetic ganglionic neurotransmission in humans. Am J Physiol Regul Integr Comp Physiol 269: R406-R412, 1995.
8. Herring N, Zaman JAB, Paterson DJ. Natriuretic peptides like NO facilitate cardiac vagal transmission and bradycardia via a cGMP pathway. Am J Physiol Heart Circ Physiol 281: H2318-H2327, 2001.
9. Hopkins DA, Bieger D, deVente J, Steinbusch WM. Vagal efferent projections: viscerotopy, neurochemistry and effect of vagotomy. Prog Brain Res 107: 79-96, 1996.
10. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldmannd AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, Noble J, Packer M, Silver MA, Stevenson LW. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. Circulation 104: 2996-3007, 2001.
11. Jones JFX, Wang Y, Jordan D. Heart rate responses to selective stimulation of cardiac vagal C fibres in anesthetized cats, rats and rabbits. J Physiol 489: 203-214, 1995.
12. Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A, Esler M. Adverse consequences of high sympathetic nervous activity in the human failing heart. J Am Coll Cardiol 26: 1257-1263, 1995.
13. Kuras A, Gutmaniene N. Preparation of carbon-fibre microelectrode for extracellular recording of synaptic potentials. J Neurosci Methods 62: 207-212, 1995.
14. La Rovere MT, Bigger JT, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 351: 478-484, 1998.
15. Lipski J. Antidromic activation of neurones as an analytical tool in the study of the central nervous system. J Neurosci Methods 4: 1-32, 1981.
16. Maisel AS. Nesiritide: a new therapy for the treatment of heart failure. Cardiovasc Toxicol 3: 37-42, 2003.
17. McAllen RM, Spyer KM. The baroreceptor input to cardiac vagal motoneurones. J Physiol 282: 365-374, 1978.
18. McKinley MJ, McAllen RM, Davern P, Giles ME, Penschow J, Sunn N, Uschakov A, Oldfield BJ. The sensory circumventricular organs of the mamalian brain. Adv Anat Embryol Cell Biol 172: 1-122, 2003.
19. Quintin L, Gillon JY, Saunier CF, Chouvet G, Ghignone M. Continuous volume infusion improves circulatory stability in anesthetized rats. J Neurosci Methods 30: 77-83, 1989.
20. Rentero N, Cividjian A, Trevaks D, Pequignot JM, Quintin L, McAllen RM. Activity patterns of cardiac vagal motoneurons in rat nucleus ambiguus. Am J Physiol Regul Integr Comp Physiol 283: R1327-R1334, 2002.
21. Schultz HD, Gardner DG, Deschepper CF, Coleridge HM, Coleridge JC. Vagal C-fiber blockade abolishes sympathetic inhibition by atrial natriuretic factor. Am J Physiol Regul Integr Comp Physiol 255: R6-R13, 1988.
22. Thomas CJ, Allen AM, McAllen RM, Woods RL. ANP potentiates nonarterial baroreflex bradycardia: evidence from sinoaortic denervation in rats. Auton Neurosci 97: 89-98, 2002.
23. Thomas CJ, May CN, Sharma AD, Woods RL. ANP, BNP, and CNP enhance bradycardic responses to cardiopulmonary chemoreceptor activation in conscious sheep. Am J Physiol Regul Integr Comp Physiol 280: R282-R288, 2001.
24. Thomas CJ, Rankin AJ, Head GA, Woods RL. ANP enhances bradycardic responses in normotensive but not spontaneously hypertensive rats. Hypertension 29: 1126-1132, 1997.
25. Thomas CJ, Woods RL. Guanylyl-cyclase receptors mediate cardiopulmonary vagal reflex actions of ANP. Hypertension 41: 279-285, 2003.
26. Thomas CJ, Woods RL. Do natriuretic peptides modify arterial baroreflexes in sheep? Exp Physiol 89: 709-715, 2004.
27. Thomas CT, Head GA, Woods RL. Cardiac reflex actions of atrial, B-type and C-type natriuretic peptides in conscious rats. J Hypertens 17: 801-806, 1999.
28. Thoren P, Mark AL, Morgan DA, O'Neal TP, Needleman P, Brody MJ. Activation of vagal depressor reflexes by atriopeptins inhibits renal sympathetic activity. Am J Physiol Heart Circ Physiol 251: H1252-H1259, 1986.
29. Vanoli E, DeFerrari GM, Stramba-Badiale M, Hull SS, Foreman RD, Schwartz PJ. Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ Res 68: 1471-1481, 1991.
30. Wang Y, Jones JFX, Jeggo RD, de Burgh Daly M, Jordan D, Ramage AG. Effect of pulmonary C-fibre afferent stimulation on cardiac vagal neurones in the nucleus ambiguus in anesthetized rats. J Physiol 526: 157-165, 2000.
31. Woods RL. Cardioprotective functions of atrial natriuretic peptide and B-type natriuretic peptide: a brief review. Clin Exp Pharmacol Physiol 31: 791-794, 2004.
32. Woods RL, Jones MJM. Atrial, B-type and C-type natriuretic peptides cause mesenteric vasoconstriction in conscious dogs. Am J Physiol Regul Integr Comp Physiol 276: R1443-R1452, 1999.